14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
As life under lockdown begins to feel like the 'new norm', we have created two snapshots of the key ...
Read More >
In this episode Jonathan Armstrong and Tom Fox are back to discuss issues relating to data privacy, ...
Read More >
Seyfarth Synopsis: The California Supreme Court has held that an individual may not seek unpaid wage...
Read More >
The Small Business Administration (SBA) issued a Procedural Notice on October 2, 2020, detailing re...
Read More >
In a significant development for the mergers and acquisitions (“M&A”) community, the U.S. Small Bu...
Read More >
The ADA Amendments Act of 2008 (ADAAA) substantially lowered the bar for plaintiffs to demonstrate a...
Read More >